AROVI® is the enoxaparin sodium marketed in the UK and manufactured by ROVI, European specialist in heparins.
AROVI® Administration VIDEO
USER INFORMATION GUIDE
Enoxaparin sodium is a widely-used Low Molecular Weigh Heparin (LMWH) amongst its class. Enoxaparin’s safety and efficacy have been established in a wide range of both arterial and venous thromboembolic conditions. For this reason, it is recommended by several practice guidelines and frequently used in everyday practice.
Enoxaparin sodium is a Low Molecular Wight Heparin (LMWH) widely-used amongst its class in a wide range of both arterial and venous thromboembolic conditions. It is recommended by several practice guidelines and frequently used in everyday practice.
ROVI Quality processes
The manufacturing process of our AROVI ® is vertically integrated from the manufacture of the active ingredient enoxaparin sodium to manufacturing of the finished form and packaging.
AROVI® is manufactured entirely in our European plants: the active ingredient (enoxaparin sodium) is produced in our factory in Granada (Spain). At our factory in Madrid (Spain), the finished product is produced, packaged and shipped from there. The annual production capacity of our factory is 250 million pre-filled syringes.
Both plants have GMP certificate and have been audited and approved by the FDA and other regulatory agencies (ANVISA, AEMPS, KFDA...).